Goldman Sachs Adjusts Price Target on Thermo Fisher Scientific to $650 From $655, Maintains Buy Rating
Thermo Fisher Scientific Introduces Ambient Shipping Solution for Its Invitrogen Antibodies to Help Customers Reduce Packaging Waste and Carbon Emissions
Robots in the usa factory are starting to "lose their jobs"...
①In the USA factory, the work left for new siasun robot&automation seems to be decreasing... ②Many business executives express that as production lines and workshop businesses slow down, manufacturers are reducing the purchase of automation equipment; ③At the same time, in the USA labor market, more human workers are queuing up to find jobs.
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
(TMO) - Analyzing Thermo Fisher Scientific's Short Interest
Thermo Fisher Scientific Showcases Expanded Biopharma Services, Capabilities and Innovations at CPHI Milan 2024
loading...
...
CY90 : Major is Reit. wow
YOHO3318 OP CY90 : yeah, as REITs are required to distribute at least 90% of their income
Mr Pistachio : DBS is a divd ATM long term hold but your cost basis in the teens is best
YOHO3318 OP Mr Pistachio : waiting for it to pull back to collect more =)
Chilli Doggie : The anticipation for the rate cut had been dragged too long contributing to the uptrend. Could pullback or push even higher once announcement is made.
I’m just waiting for the hype to end before adding more REIT positions.
View more comments...